Allena Pharmaceuticals, Inc.

📍 Newton, United States🗓 Founded 2011👥 15 employees💰 Last funded 2021
Biotechnology🌐 allenapharma.com
Website LinkedIn
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney. The company is focused on metabolic disorders that result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease, or CKD, and end-stage renal disease. Allena’s proprietary technological approach enables the design, formulation and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. This approach utilizes the GI tract to degrade metabolites, such as oxalate and urate, reducing plasma and urine levels, and in turn, reducing their disease burden on the kidney over time. See our social media community guidelines - https://www.allenapharma.com/social-media-community-guidelines
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Allena Pharmaceuticals, Inc.?
Allena Pharmaceuticals, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Allena Pharmaceuticals, Inc. last raise funding?
The most recent investment in Allena Pharmaceuticals, Inc. recorded on gritt.io was in 2021.
When was Allena Pharmaceuticals, Inc. founded?
Allena Pharmaceuticals, Inc. was founded in 2011.
What industry is Allena Pharmaceuticals, Inc. in?
Allena Pharmaceuticals, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Allena Pharmaceuticals, Inc. based?
Allena Pharmaceuticals, Inc. is headquartered in Newton, United States.